Dopaminergic D1 and D2 receptor antagonists decrease prosomatostatin mRNA expression in rat striatum.
The effect of acute dopamine receptor antagonist treatment on cellular prosomatostatin mRNA expression was investigated in the adult rat striatum using the technique of non-radioactive in situ hybridization. Adult female Wistar rats were given a single intraperitoneal injection of either raclopride (D2 antagonist), SCH 23390 (D1 antagonist) or the D1 (S) enantiomer SCH 23388. Animals were killed either 1, 3 or 9 h following the single i.p. injection and their brains rapidly removed. Striatal sections were then processed for in situ hybridization using an alkaline phosphatase-labelled oligonucleotide probe complementary to a portion of the rat somatostatin cDNA. Blockade of dopamine D1 and D2 receptors resulted in a significant decrease in the cellular content of prosomatostatin mRNA. However, no change in the number of prosomatostatin mRNA containing striatal cells was observed following any of the treatments at any time point. These findings demonstrate that the cellular content of prosomatostatin mRNA in the adult rat striatum is influenced by selective dopamine D1 and D2 receptor antagonists. Further, these findings are consistent with a functional interaction between dopamine and somatostatin in the rat striatum.
Department of Neuroendocrinology, A.F.R.C. Institute of Animal Physiology & Genetics Research, Babraham, Cambridge, U.K.
S J
SJ
Augood
H
H
Kiyama
R L
RL
Faull
P C
PC
Emson
D000818:Animals; D001552:Benzazepines / Q000494:pharmacology*; D002452:Cell Count / Q000187:drug effects; D003342:Corpus Striatum / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D018492:Dopamine Antagonists; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D009693:Nucleic Acid Hybridization; D011498:Protein Precursors / Q000096:biosynthesis* / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis; D020891:Raclopride; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology*; D012457:Salicylamides / Q000494:pharmacology*; D013004:Somatostatin / Q000096:biosynthesis* / Q000235:genetics
D001552:Benzazepines; D018492:Dopamine Antagonists; D011498:Protein Precursors; D012333:RNA, Messenger; D011954:Receptors, Dopamine; D012457:Salicylamides; D020891:Raclopride; D013004:Somatostatin; C028456:prosomatostatin